Roles
Professor of Clinical Pediatrics
Director, Hemophilia and Thrombosis Comprehensive Treatment Center
Medical Director, Pediatric Hemophilia Program
Director, Pediatric Hematology-Oncology Fellowship Program
-
Biography
Dr. Fernando Corrales-Medina is a Professor of Clinical Pediatrics at the University of Miami-Miller School of Medicine, Division of Pediatric Hematology-Oncology, where he serves as the director of the University’s Comprehensive Hemophilia and Thrombosis Treatment Center, medical director for the pediatric hemophilia program and director for the pediatric hematology-oncology fellowship program.
After attending medical school in Peru, he completed his general pediatrics training at Jackson Memorial/University of Miami in 2011, followed by his pediatric hematology-oncology fellowship at The University of Texas – MD Anderson Cancer Center, from which he graduated in 2014.
Dr. Corrales-Medina’s primary academic interests are von Willebrand disease (VWD),hemophilia A, women with bleeding disorders, novel hemostatic therapies, and the use of point-of-care musculoskeletal ultrasound in bleeding disorders. He is the Principal Investigator for several pharmaceutical, as well as investigator-initiated, research studies. His work has been published in several peer-reviewed journals, including Blood Reviews, Haemophilia, Journal of Thrombosis and Haemostasis, Research and Practice in Hemostasis and Thrombosis, among others.
Dr. Corrales-Medina has received several research and teaching awards including the 2018 American Thrombosis and Hemostasis Network (ATHN) - DREAM Award. Currently, he is the director of the University of Miami-VWD Academy for Latin America and the principal investigator for the global initiative “VWDtest.com” and the ATHN Transcends-Hemophilia Natural History Arm Study. -
Education & Training
Education
Post Graduate Training
Licensures and Certifications
-
Honors & Awards
No result found
-
Teaching Interests
Dr. Fernando F. Corrales-Medina’s teaching interests center on pediatric hematology, with particular expertise in hemostasis and thrombosis, including hemophilia, von Willebrand disease, rare bleeding disorders, pediatric thrombosis, and anticoagulation. His educational approach emphasizes the integration of pathophysiology, clinical reasoning, and evidence-based medicine, with the goal of helping learners translate increasingly complex diagnostic and therapeutic advances into thoughtful, individualized patient care.
As Director of the Pediatric Hematology-Oncology Fellowship Program at the University of Miami, Dr. Corrales-Medina is actively involved in graduate medical education and the training and mentorship of fellows, residents, medical students, and other healthcare professionals. He has a particular interest in developing clinical reasoning and progressive independence among trainees, while emphasizing critical appraisal of the medical literature, multidisciplinary collaboration, effective communication, and patient-centered decision-making.
An important component of his teaching focuses on hemostasis and thrombosis education. He teaches learners to approach bleeding and thrombotic disorders systematically, integrating the clinical phenotype with laboratory findings and recognizing the limitations of diagnostic testing. His educational interests also include the rapidly evolving therapeutic landscape in hemophilia and other bleeding disorders, appropriate use of anticoagulant therapies, and the incorporation of point-of-care musculoskeletal ultrasound into the comprehensive assessment of patients with hemophilia.
Beyond institutional education, Dr. Corrales-Medina is committed to expanding education in bleeding disorders through national and international programs. He has developed and participated in educational initiatives for physicians and multidisciplinary healthcare professionals, with a particular emphasis on Latin America and the Caribbean. Through these efforts, he seeks to promote evidence-based, practical approaches that can be adapted to different healthcare environments and levels of available resources.
Across his educational activities, Dr. Corrales-Medina views mentorship as an essential component of academic medicine. His teaching aims not only to develop clinical expertise, but also to foster intellectual curiosity, scholarly inquiry, leadership, and the skills necessary for trainees to become independent clinicians, educators, and investigators. -
Research Interests
Dr. Fernando F. Corrales-Medina’s research focuses on improving the diagnosis, treatment, and long-term outcomes of children and adults with inherited bleeding and thrombotic disorders. His work is centered on translating advances in hemostasis and thrombosis into clinically meaningful improvements in patient care, with particular emphasis on von Willebrand disease (VWD), hemophilia, rare bleeding disorders, and pediatric thrombosis.
A major area of his research is the recognition and diagnosis of VWD and other inherited bleeding disorders, particularly in children, adolescents, and women with heavy menstrual bleeding. His work has examined the clinical utility and limitations of conventional laboratory testing, bleeding assessment tools, and specialized von Willebrand factor assays, with the goal of identifying patients who may otherwise remain undiagnosed. He is also involved in initiatives using digital tools to improve recognition of abnormal bleeding and facilitate access to appropriate evaluation.
In hemophilia, Dr. Corrales-Medina’s research interests include contemporary prophylaxis, non-factor therapies, treatment individualization, joint health, and the evolving definition of optimal hemostatic protection. His work incorporates clinical outcomes and point-of-care musculoskeletal ultrasound to better characterize joint health and support individualized treatment decisions. He also participates in multicenter observational research evaluating the natural history and real-world treatment of people with hemophilia and other inherited bleeding disorders.
His research in thrombosis focuses on pediatric and young-adult venous thromboembolism, thrombophilia, anticoagulant therapy, and anticoagulation stewardship, including populations with complex chronic disease and elevated thrombotic risk. Across these areas, he is particularly interested in determining how laboratory findings and emerging diagnostic technologies should be translated into decisions that meaningfully alter clinical management.
An additional focus of his academic work is reducing disparities in the recognition and management of bleeding disorders through education, international collaboration, and capacity building, particularly in Latin America and other resource-limited settings. Ultimately, his research seeks to bridge diagnostic science, therapeutic innovation, and real-world clinical practice to deliver more precise, accessible, and patient-centered care for individuals with bleeding and thrombotic disorders. -
Publications
Disclaimer: The information presented in this section has been consolidated using AI and machine learning technologies. While every effort has been made to ensure accuracy, errors may occur. If you identify any inaccuracies, please use this link to inform our data team. Your feedback is greatly appreciated and helps us improve the quality of our content.
-
Professional Activities
No result found